Welcome to our dedicated page for Moringa Acquisition Warrant news (Ticker: MACAW), a resource for investors and traders seeking the latest updates and insights on Moringa Acquisition Warrant stock.
Moringa Acquisition Corp (Nasdaq: MACA) is a blank check company focused on effecting a business combination with Israel-related technology companies. Recently, Moringa announced a merger with Silexion Ltd., an oncology-focused biotechnology company, with promising products like Loder™ showing significant efficacy in clinical trials. The proposed merger aims to provide shareholders the opportunity to participate in Silexion's innovative platform as a publicly listed Nasdaq company.
Moringa Acquisition Corp (NASDAQ: MACA) announced the adjournment of its Extraordinary Meeting, initially scheduled for February 7, 2023, to February 9, 2023. This meeting aims to vote on extending the deadline for completing a business combination from February 19, 2023, to August 19, 2023. Shareholders are advised to participate and review the Definitive Proxy Statement filed with the SEC. The company previously entered into a business combination agreement with Holisto Ltd., a tech-powered travel agency. The record date for shareholders to vote remains January 3, 2023.
On June 13, 2022, Holisto Ltd and Moringa Acquisition Corp (Nasdaq: MACA) announced a merger agreement, enabling Holisto to become publicly listed. The combination values Holisto at approximately $405 million and provides non-redeeming Moringa shareholders with a bonus of up to 1,725,000 shares. Holisto, leveraging AI technology, aims to disrupt the $194 billion online hotel booking market with personalized offerings. The transaction is expected to close in Q4 2022, subject to shareholder and Nasdaq approvals.
Moringa Acquisition Corp (NasdaqCM: MACA, MACAU, MACAW) filed its annual report on Form 10-K for the year ended December 31, 2021, with the SEC on March 31, 2022. This report is accessible through their official website and the SEC's site. The company targets mergers and acquisitions, particularly focusing on technology firms related to Israel. The press release also includes a reminder that forward-looking statements are based on management's beliefs and assumptions, and actual results may differ due to various factors.
Moringa Acquisition Corp has announced the pricing of its initial public offering (IPO) at $10.00 per unit, totaling 10,000,000 units. The units will be listed on Nasdaq under the symbol 'MACAU' starting February 17, 2021. Each unit includes one Class A ordinary share and one-half of a redeemable warrant, allowing the purchase of additional shares at $11.50. The Company aims to focus on Israel-related technology firms and has engaged EarlyBirdCapital, Inc. and Moelis & Company as joint book-running managers. A registration statement was approved by the SEC on February 16, 2021.
FAQ
What is the current stock price of Moringa Acquisition Warrant (MACAW)?
What is Moringa Acquisition Corp?
Who is Silexion Ltd?
What is the purpose of the merger between Moringa and Silexion?
What are the key transaction terms of the business combination?
When is the expected closing date of the merger?
What are the main products developed by Silexion?
Who are the legal counsels for Moringa and Silexion?
Where can shareholders find more information about the proposed business combination?
What are the risks associated with the proposed transaction?
Who are the participants in the solicitation for the business combination?
